Regencor, Inc.
San Carlos, USA
|
Regencor is a regenerative medicine company focused on developing cardiac regenerative therapies that target myocardial infarction and heart failure. The company is developing two different formulations for their proprietary API, (non-glycosylated rhFSTL1), to enable the delivery of the regenerative protein directly to the human heart during PCI or CABG procedures, thereby transforming coronary revascularization into cardiac regeneration.